The effects of corticosteroid treatment on growth and skeletal maturation were evaluated in 189 children with severe asthma who were referred for care a t a residential treatment center. Height age on admission was significantly retarded in 8-10% of patients who had received little corticosteroid treatment previously and in 35% of patients who had taken steroids daily for more than 2 years. Children who had been treated with steroids intermittently or on alternate days were comparable to those who had taken steroids rarely. During an average residential period of 17 months, patients whose daily steroid treatment was discontinued had a relative gain in height age of 5 months; children who were started on daily steroids had a 5-month delay in growth. Evaluation of skeletal maturation a t the time of admission revealed that skeletal age was more retarded than height age in the boys and less retarded than height age in the girls. During the period of residence, the changes in bone age paralleled the changes in height age.
Extract
The effects of corticosteroid treatment on growth and skeletal maturation were evaluated in 189 children with severe asthma who were referred for care a t a residential treatment center. Height age on admission was significantly retarded in 8-10% of patients who had received little corticosteroid treatment previously and in 35% of patients who had taken steroids daily for more than 2 years. Children who had been treated with steroids intermittently or on alternate days were comparable to those who had taken steroids rarely. During an average residential period of 17 months, patients whose daily steroid treatment was discontinued had a relative gain in height age of 5 months; children who were started on daily steroids had a 5-month delay in growth. Evaluation of skeletal maturation a t the time of admission revealed that skeletal age was more retarded than height age in the boys and less retarded than height age in the girls. During the period of residence, the changes in bone age paralleled the changes in height age.
Speculation
Suppression of growth is a frequent complication in asthmatic children who receive prolonged treatment with corticosteroids. In some patients the suppression of growth may result in permanent dwarfism. However, no information is currently available on the adult heights of patients who have received prolonged corticosteroid therapy during childhood.
It is well known that prolonged corticosteroid therapy in children may be associated with the inhibition ofgrowth. However, there are still a number of unanswered questions with respect to the frequency and severity of the dwarfism induced by corticosteroids, the possible contributory influence of the underlying disease, and the likelihood of "catch-up" growth after corticosteroid therapy is discontinued. Additionally, more information is needed about the effects of corticosteroid treatment on the skeletal maturation of children without endocrine disease. In this study the influence of corticosteroid therapy on height and skeletal maturation was evaluated in a large population of children with asthma.
MATERIALS AND METHODS

PATIENTS
All children had severe asthma and had been referred for care at a residential treatment center in Denver. The study was based on a retrospective evaluation of two population groups: children in residence at the center in 1965 and those admitted in 1970. The ages of both groups (Table I) ranged between 6 and 15 years, with a mean age of 11. Most of the patients were Caucasian children from middle income families. The larger number of boys reflects the population at the treatment center.
The initial phase of the study was based on evaluation of height and skeletal maturation at the time of admission in 189 children. The number of subjects in this portion of the study permitted separate evaluation of the data in boys and girls.
The second phase of the study was based on evaluation of the changes in physical development during the period of residential care. For this purpose comparisons were made of height and skeletal ages at the time of admission and discharge in 76 children (49 boys and 27 girls). The duration of residential treatment ranged between 12 and 24 months with an average of 17 months. This portion of the study is largely based on data of children hospitalized during 1965.
EXPERIMENTAL APPROACH
T o reduce bias in interpretation of data, the study was approached first by assessment of skeletal ages from radiographs of the left hand and wrist which had been obtained during the course of routine diagnostic evaluation (22) . After the assessment of skeletal ages had been completed, the heights and weights of the patients at the time of the x-ray examinations were abstracted from the charts and recorded separately. The patients' charts were then reviewed without regard to the growth data and an assessment was made of the course and severity of the asthma and the history of steroid therapy.
EVALUATION O F SKELETAL DATA Skeletal ages were determined by the author through comparison of radiographs of the left wrist with the standards in a Greulich-Pyle atlas (9) . In some instances the assessment of bone age was especially difficult because the maturation ages suggested by primary centers (carpals) were markedly delayed in comparison with the secondary (long bone) epiphyses. Although similar discrepancies in maturation have been observed in healthy children (8, lo) , the frequency and severity of the imbalance appeared to be unusually great in our study population. Because of the imbalance, attempts to determine skeletal ages on the basis of all bones in the hands and wrists (18) sometimes resulted in low readings which could change markedly when subsequent films of the same patient were examined, if the extent of the imbalance decreased. For the purpose of this study, skeletal ages were therefore assigned on the basis of the more mature digital epiphyses rather than the less mature carpal ossification centers. Other investigators have also suggested that carpal ossification may be ignored in the assessment of maturation when the carpals differ markedly from the digits (I, 15, 16) .
T o evaluate the reproducibility of the bone age determinations, a group of 66 radiographs from 30 patients was reviewed by the author at the conclusion of the study, many months after the initial assessment of skeletal age. Comparison of the initial and follow up assessment of the 66 hand films, with bone ages ranging from 4.5-16 years, showed a mean difference between the two readings of 0.08 years; the standard deviation of the difference in the two determinations was * 0.30 years ( S D =m). Re-evaluation of the magnitude of change in bone age in 35 paired films taken during the residential period revealed that the standard deviation of the differences in the two assessments was 0.36 years; mean difference = 0.15 years.
The determination of height age was based on the mean heights of normal children in the Iowa City study (19) . The calculated difference between height age and chronologic age provided an indication of the amount of retardation in growth of each patient. Group data were evaluated by standard statistical methods (7). Weight was not used as an index of growth in this study because of the variable influence of corticosteroid treatment on total body weight and lean body mass.
EVALUATION O F S T E R O I D P R O G R A M
The program of corticosteroid treatment before admission was classified on the basis of frequency and duration into three broad categories: (1) "rare," no steroid or short courses administered infrequently; (2) "intermittent," steroid therapy given on alternate days or during many short courses, with periods of days or weeks of no steroid therapy for at least 2 years; (3) "frequent," daily treatment for at least 2 years (mean duration in the group 3.5 years) or frequent prolonged courses with only short periods off steroids for at least 3 years. Treatment could not be evaluated in relation to the steroid preparation or specific steroid dose.
Evaluation of the influence of steroid treatment during the period of residential care was based on data of children who could be separated clearly into I of 2 subgroups: (1) no steroid during residence or (2) daily steroids throughout the period of residence. In all instances prednisone was used for maintenance therapy. The majority of patients who required continued daily treatment with steroids received 10-20 mg/24 hr prednisone. However, the exact dose varied from one patient to another and from one time to another. Additionally, there was considerable variability in the amount anf frequency of supplemental steroids (intravenous hydrocortisone or Solu-Medrol) given for treatment of acute episodes of asthma. The data in this study were therefore evaluated solely on the basis of whether or not steroid treatment was administered on a daily schedule. Because of the small size of the groups, no attempt was made to separate the data further in relation to the specific amounts of steroid given.
RESULTS P H Y S I C A L G R O W T H A N D M A T U R A T I O N A T T I M E O F ADMISSION
boys and girls admitted to the center in 1965 and 1970. The alteratidns in development were similar in the two groups, but children of both sexes were relatively shorter for age in 1970 than in 1965. The greater severity of growth retardation in the 1970 group may reflect the greater proportion of steroid-treated patients admitted to the center in recent years (6) . In a few instances genetic or nutritional factors may have contributed to the short stature but in the majority of patients no causes for shortness could be found other than those related to asthma or corticosteroid treatment. The parents' heights were well within normal limits: fathers, 69.5 inches * S D 2.5 ( n = 83); mothers, 63.9 inches A S D 2.9 ( n = 87). Table 2 summarizes the relationship between previous corticosteroid treatment and growth inhibition. Even when asthmatic children had received little or no corticosteroid therapy, there was a moderate delay of 7-8 months in average height age. The magnitude of retardation in growth increased as the frequency of steroid therapy increased. The retardation in height age was comparable in boys and girls who had received similar programs of treatment. However, there was a marked difference in the bone maturation of the two sexes. In girls, the retardation of skeletal age was less than the delay in height age; in boys the delay in skeletal age was considerably greater than the alteration in height.
Evaluation of the distribution of patients whose heights were more than 2 S D below the mean for normal children of the same .age and sex revealed that growth was retarded in 8-10% of the asthmatic children who had received little or no corticosteroid ' Although similar alterations in development were observed in boys and girls, results in the smaller number of girls did not achieve statistical significance.
'Significantly different from chronologic age (P < 0.05 to < 0.001). Table 1 summarizes the overall age and de~elopmental data of treatment. The incidence of growth inhibition was minimally altered by "intermittent" treatment with corticosteroids. However, when children had been given daily steroid therapy for prolonged periods, the frequency of growth inhibition rose to 35%.
CHANGE IN GROWTH A N D MATURATION DURING PERIOD OF RESI-DENTIAL TREATMENT
The influence of corticosteroid treatment on growth was further evaluated in 76 children who received residential treatment for an average period of 1.41 years ( I 7 months). Children were separated into groups based on the programs of corticosteroid treatment before admission and during residence. As shown in Table 3 , growth was assessed by comparison of the differences between height age and chronologic age at the time of admission and discharge. It was found that children whose steroid programs were not changed appreciably during residence maintained similar patterns of growth before and after admission. Thus, children in group 1 who did not receive corticosteroid treatment were normal in size at the time of admission and grew at a normal rate during the residential period. Children in group IIa who had previously received steroids "intermittently" had minimal delay in growth a t the time of admission and showed only a slight gain in height age of 2 months (relative to chronologic age) after corticosteroids were discontinued. The retardation of growth in group IVb, who had previously taken steroids "frequently," also did not change significantly during the period of daily steroid therapy at the institute.
There wert three groups ( I l b , I l l , and IVa) in which the differences between height and chronologic ages changed significantly during the residential period. In all three groups, the changes in growth were associated with major changes in the program of corticosteroid treatment. The relative changes in height age of the patients included in these groups are illustrated in Figure I . Children in group Ilb whose daily steroid treatment was discontinued had acceleration of growth. During the residential period of 17 months (approximately 16 months after steroids were discontinued), the increase in height age exceeded the advance in chronologic age by an average of 0.39 years (4.7 months), P < 0.01. Conversely, 17 of the 21 patients in groups 111 and IVa who were started on daily steroid therapy exhibited further delay in growth during the period of residence. The magnitude of delay in growth was similar in children who had previously taken steroids "rarely" (group 111, P < 0.02) and in those who had taken steroids "intermittently" before admission (group IVa, P < 0.05). In both groups, the average increase in height age was only 12.7 months during the 18 months of residence at the institute.
There was a fairly close correspondence between growth in height and skeletal maturation during the period of residence. In most groups, the average change in skeletal age during the residential period approached the differences observed in height ages (Table 3) . However, the changes in rate of skeletal maturation ' Expressed as years of retardation in comparison with chronologic age. 2Change during residence: +: acceleration of growth; -: progression of the growth retardation; t: significant change in height age during residence. Table 3 for summary of group averages.
during the period of residence did not achieve statistical significance.
Apart from the influence of corticosteroid therapy, there was a further suggestion in Table 3 that the severity of asthma also contributed to the growth retardation. Since the policy at the center is to discontinue corticosteroid therapy whenever possible, the daily administration of steroids during the period of residence may be taken as an indication of the severity of the disease or at least the difficulty in controlling symptoms. It was of interest therefore that in children with similar histories of previous therapy (groups I and 111) and (groups I l a and IVa), the severity of the growth retardation at the time of admission appeared to vary in relation to the subsequent program of treatment at the institute. Although the differences in the small groups were not statistically significant, children who required daily steroid treatment at the institute had greater retardation of height and skeletal maturation at the time of admission than did those who could subsequently be managed without steroid therapy.
DISCUSSION
The present results demonstrate that suppression of growth is a frequent complication in children with severe asthma. In our population, growth was moderately delayed even in the absence of corticosteroid therapy. This may have resulted from the hypoxia which is often associated with severe asthma (12, 20) and which may persist even in the absence of symptoms (21) . In addition, however, the program of corticosteroid treatment exerted a profound influence on skeletal growth and maturation. When steroids were administered intermittently, the delay in growth was only slightly greater than that observed in the absence of steroid medication. However, when steroids were given daily for prolonged periods, there was a marked increase in both the frequency and severity of the growth retardation.
During the period of residential care, the catch-up in growth observed in patients whose daily steroid therapy was discontinued was almost identical with the amount of delay in growth exhibited by children who were started on daily steroids. These observations suggest that in asthmatic patients, the time required may equal the time required for development of the growth retardation. The present results differ from those of others who have reported that the "catch-up" growth after the removal of an adrenal tumor or alleviation of other chronic diseases may approach 3 or 4 times the normal rate (13) . Other investigators, however, have also observed that the "catch-up" growth after an illness (2) or after correction of congential heart defects (3, 5 ) may be relatively slow and incomplete. In our children, the persistence of asthma may have contributed to the slow catch-up in growth after discontinuation of daily corticosteroid treatment.
Evaluation of skeletal age was extremely difficult in our study population because of marked discrepancies in the maturation of the carpals as compared with the digital epiphyses. It was subsequently found that the larger discrepancies occurred in children who had received frequent corticosteroid treatment. When skeletal ages were assigned on the basis of the more mature ossification centers, the retardation of maturation was somewhat less severe than the retardation of growth in the girls; in boys, the changes in maturation appeared to be more severe than the retardation in height age. During the period of residential care, the changes in bone maturation paralleled the changes in height age in both sexes.
It has been suggested that corticosteroid treatment may cause greater suppression of bone age than height in children without endocrine disease (4, 11) . The present data suggest such a trend in the boys, but not in the girls. Although it is possible that the effects of corticosteroid treatment on skeletal maturation differ in the two sexes, other factors may have contributed to the differences between the boys and the girls observed in this study. Schoen et al. (17) have reported that bone age appears to be excessively retarded in boys of short stature even when there is no apparent disease, suggesting that hand films from normal boys may not be suitable standards for evaluation of bone maturation in patients with altered patterns of growth. Additionally, there was a probable difference in the pubertal development of the two sexes. Although the mean ages of both groups were similar (1 I years), girls of this age are approaching or have already entered puberty, while the majority of boys are prepubertal. A trend toward acceleration of bone maturation during early puberty may have contributed to the lesser degree of retardation in skeletal maturation of the girls. It was noteworthy, however, that the retardation of height remained comparable in both sexes.
The observations that catch-up growth after discontinuation of corticosteroid treatment is relatively show in asthmatic children and that the growth inhibition may not be reversed during the pubertal period suggest that prolonged steroid therapy during childhood might result in permanent dwarfism. Unfortunately, information concerning the adult heights of patients who have received prolonged steroid therapy during childhood is not currently available and is greatly needed. At the present time, the most beneficial approach to the prevention of steroid-induced dwarfism seems to involve manipulation of the program of corticosteroid treatment. Current observations suggest that the administration of corticosteroids on an intermittent or alternateday basis may be associated with considerably less suppression of growth than that which results from daily therapy (14) .
SUMMARY
The program of corticosteroid therapy has a profound influence on the growth and skeletal maturation of children with asthma. The suppression of growth is also influenced by the severity of the asthma.
